Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 16,516 | 17,482 | 16,342 | 15,847 | 13,780 |
| Operating Income | -16,516 | -17,482 | -16,342 | -15,847 | -13,780 |
| Interest Expense | 1,207 | 719 | 352 | 0 | 0 |
| Other Income | 891 | 819 | 379 | 35 | 15 |
| Pre-tax Income | -16,832 | -17,382 | -16,315 | -15,812 | -13,765 |
| Income Tax | N/A | -40 | -107 | 154 | 63 |
| Net Income Continuous | -16,832 | -17,342 | -16,208 | -15,966 | -13,828 |
| Minority Interests | -8,460 | -8,556 | -8,253 | -8,342 | -7,605 |
| Net Income | $-8,372 | $-8,786 | $-7,955 | $-7,624 | $-6,223 |
| EPS Basic Total Ops | -0.33 | -0.35 | -0.33 | -0.31 | -0.29 |
| EPS Basic Continuous Ops | -0.67 | -0.70 | -0.66 | -0.66 | -0.65 |
| EPS Diluted Total Ops | -0.33 | -0.35 | -0.33 | -0.31 | -0.29 |
| EPS Diluted Continuous Ops | -0.67 | -0.70 | -0.66 | -0.66 | -0.65 |
| EBITDA(a) | $-16,969 | $-17,891 | $-16,392 | $-15,725 | $-13,669 |